tubercidin has been researched along with telaprevir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Abe, H; Chayama, K; Hayes, CN; Hiraga, N; Hirata, D; Imamura, M; Iwao, E; Kamiya, N; Kawaoka, T; Kono, T; Mitsui, F; Ochi, H; Ohara, E; Onishi, M; Takahashi, S; Tanaka, S; Tateno, C; Tsuge, M; Yamada, I; Yoshizato, K | 1 |
2 other study(ies) available for tubercidin and telaprevir
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice.
Topics: Animals; Antiviral Agents; Cells, Cultured; Chimerism; Disease Models, Animal; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Humans; Mice; Mice, SCID; Oligopeptides; Tubercidin; Viral Nonstructural Proteins; Virus Replication | 2011 |